Publications - Drake Laboratory

  1. Stoyanova T, Riedinger M, Lin S, Faltermeier CM, Smith BA, Zhang KX, Going C, Goldstein AS, Lee JK, Drake JM, Rice M, Hsu E, Nowroozizadeh B, Castor B, Orellana SY, Blum SM, Cheng D, Pienta KJ, Reiter R, Pitteri S, Huang J, Witte ON (2016) Activation of Notch1 Synergizes with Multiple Pathways in Promoting Castration Resistant Prostate CancerPNAS. PMID: 27694579
  2. Drake JM*,#, Paull, EO*, Graham NA, Lee JK, Smith, BA, Titz, B, Stoyanova TS, Faltermeier CM, Carlin DE, Flemming DT, Wong CK, Newton Y, Sudha S, Vashisht AA, Huang J, Wohlschlegel JA, Graeber TG, Witte ON#, Stuart JM# (2016) Phosphoproteome Integration Reveals Patient-Specific Networks in Prostate CancerCell. 166(4):1041-1054. *Authors contributed equally to this work. #Co-corresponding author.
    - Editor’s choice commentary in Science Translational Medicine
    - News and Views commentary in Nature Reviews Urology
  3. Faltermeier CM, Drake JM, Clark PM, Smith BA, Zong Y, Volpe C, Mathis C, Morrissey C, Castor B, Huang J, Witte ON (2016) Functional Screen Identifies Kinases Driving Prostate Cancer Visceral and Bone Metastasis. PNAS. 113(2):E172-E181. PMCID: PMC4720329. - Featured in a commentary by Feng and Kothari in PNAS
  4. Goodwin JF, Kothari V, Drake JM, Zhao S, Dylgjeri E, Dean JL, Schiewer MJ, McNair C, Jones JK, Aytes A, Magee MS, Snook AE, Zhu Z, Den RB, Birbe RC, Gomella LG, Graham NA, Vashisht AA, Wohlschlegel JA, Graeber TG, Karnes JR, Takhar M, Davicioni E, Tomlins SA, Abate-Shen C, Sharifi N, Witte ON, Feng FY, Knudsen KE (2015) DNA-PK Mediated Transcriptional Regulation Drives Tumor Progression and Metastasis. Cancer Cell. 28(1):97-113.
  5. Drake JM and Huang J (2014) PIP5K1α Inhibition as a Therapeutic Strategy for Prostate Cancer. PNAS. 111(35):12578-12579. PMCID: PMC4156720.
  6. Drake JM, Lee JK, Witte ON (2014) Clinical Targeting of Mutated and Wild-type Protein Tyrosine Kinases in Cancer. Mol Cell Bio. 34(10):1722-1732. PMCID: PMC4019040.
  7. Stoyanova T, Cooper AR, Drake JM, Liu X, Armstrong AJ, Pienta KJ, Zhang H, Kohn DB, Huang J, Witte ON, Goldstein AS (2013) Prostate Cancer Originating in Basal Cells Progresses to Adenocarcinoma Maintained by Luminal-like Tumor-propagating Cells. PNAS. 110(50):20111-20116. PMCID: PMC3864278.
  8. Drake JM, Graham NA, Lee JK, Stoyanova T, Faltermeier CF, Sudha S, Titz B, Huang J, Pienta KJ, Graeber TG, Witte ON (2013) Metastatic Castration Resistant Prostate Cancer Reveals Intrapatient Similarity and Interpatient Heterogeneity of Therapeutic Kinase Targets. PNAS. 110(49):E4762-E4769. PMCID: PMC3856845. (Rated ‘very good’ by Faculty of 1000; Interviewed by Genomeweb for a news article)
  9. Varzavand A, Drake JM, Svensson RU, Herndon ME, Zhou B, Henry MD, Stipp CS (2012) Integrin α3β1 Regulates Tumor Cell Responses to Stromal Cells and can Function to Suppress Prostate Cancer Metastatic Colonization. Clin. Exp. Metastasis. 30(4):541-552. PMCID: PMC3604149.
  10. Stoyanova T, Goldstein AS, Cai H, Drake JM, Huang J, Witte ON (2012) Regulated Proteolysis of Trop2 Drives Epithelial Hyperplasia and Stem Cell Self-Renewal via β-catenin Signaling. Genes Dev. 26(20):2271-2285. PMCID: PMC3475800.
  11. Drake JM, Graham NA, Stoyanova T, Sedghi A, Goldstein AS, Cai H, Smith DA, Zhang H, Komisopoulou E, Huang J, Graeber TG, Witte ON (2012) Oncogene-Specific Activation of Tyrosine Kinase Networks during Prostate Cancer Progression. PNAS. 109(5):1643-1648. PMCID: PMC3277127.
  12. Goldstein AS*, Drake JM*, Burnes DL, Finley DS, Zhang H, Reiter RE, Huang J, Witte ON (2011) Purification and Direct Transformation of Epithelial Progenitor Cells from Primary Human Prostate. Nat. Protoc. 6(5):656-667. PMCID: PMC3092477. *Authors contributed equally to this work
  13. Drake JM*, Barnes JM*, Madsen JM, Domann FE, Stipp CS, Henry MD (2010) ZEB1 Coordinately Regulates Laminin-332 and β4 Integrin Expression Altering the Invasive Phenotype of Prostate Cancer Cells. J. Biol. Chem. 285(44):33940-33948. PMCID: PMC2962494. *Authors contributed equally to this work (Rated ‘good’ by Faculty of 1000)
  14. Drake JM, Danke JR, Henry MD (2010) Bone-Specific Growth Inhibition of Prostate Cancer Metastasis by Atrasentan. Cancer Biol. Ther. 9(8):605-612. Open Access.
  15. Weydert CJ, Esser AK, Mejia RA, Drake JM, Barnes JM, Henry MD (2009) Endothelin-1 Inhibits Prostate Cancer Growth In Vivo through Vasoconstriction of Tumor-Feeding Arterioles. Cancer Biol. Ther. 8(8):62-71. Open Access. (Featured in a preview by Roh and Abdulkadir)
  16. Drake JM, Strohbehn G, Moreland JG, Henry MD (2009) ZEB1 Enhances Transendothelial Migration and Represses the Epithelial Phenotype of Prostate Cancer Cells. Mol Biol Cell. 20(8):2207-2217. PMCID: PMC2669028.
  17. Drake JM, Gabriel CL, Henry MD (2005) Assessing Tumor Growth and Distribution in a Model of Prostate Cancer Metastasis using Bioluminescence ImagingClin. Exp. Metastasis. 22(8):674-684.


precision medicine at Rutgers Cancer Institute







Donate Now








Proud member of
Big Ten Cancer Research Consortium



Rutgers Health